Qureshi Sajid S, Kazi Mufaddal, Noronha Jarin, Smriti Vasundhara, Basu Sandeep, Shah Sneha, Talole Sanjay
Division of Paediatric Surgical Oncology, Department of Surgical Oncology, Tata Memorial Hospital and Advanced Centre for Training Research and Education in Cancer (ACTREC), Tata Memorial Centre, Ernest Borges Road, Parel, Mumbai, 400012 India.
Homi Bhabha National Institute (HBNI), Mumbai, India.
Indian J Surg Oncol. 2022 Mar;13(1):92-98. doi: 10.1007/s13193-021-01312-w. Epub 2021 Mar 25.
Lymph node metastasis is a considerable variable influencing postoperative American Thyroid Association (ATA) risk stratification in pediatric differentiated thyroid cancer (DTC). The primary aim of this study was to ascertain the factors predicting nodal metastasis and describe the outcomes in relation to the ATA risk. Patients 18 years or younger operated between December 2005 and December 2019 were analyzed. Demographic, clinicopathological, treatment, and outcome data were recorded. Factors associated with nodal metastasis were assessed by univariate and multivariate regression analysis. Patients were stratified into low-, intermediate-, and high-risk as per the pediatric ATA guidelines. A total of 86 patients (43% male; median [IQR] age, 12 (10-14) years) underwent surgery during the study period. Lymph node metastases were present in 70 (82.4%) patients involving the lateral (8%) and central compartment (4.7%) alone and both (88.6%) compartments. Extrathyroid extension (ETE) was present in 65%; 35%, minimal; and 30%, extensive. On univariate analysis, nodal metastasis was more frequent in male patients, multifocal tumor, lymphovascular invasion, and ETE. On multivariate analysis, only ETE was predictive of nodal disease with an odds ratio of 8. Minimal and extensive ETEs were both significantly associated with lymph node metastases when compared to the absence of ETE. The 5-year disease-free survival was 100%, 95.7%, and 66% in the low-, intermediate-, and high-risk groups respectively ( < 0.0001). Pediatric DTCs have an exceptionally high incidence of lymph node metastasis. ETE is the single most important predictor of nodal disease. The ATA pediatric risk stratification is useful in predicting clinical outcomes.
淋巴结转移是影响儿童分化型甲状腺癌(DTC)术后美国甲状腺协会(ATA)风险分层的一个重要变量。本研究的主要目的是确定预测淋巴结转移的因素,并描述与ATA风险相关的结果。对2005年12月至2019年12月期间接受手术的18岁及以下患者进行分析。记录人口统计学、临床病理、治疗和结果数据。通过单因素和多因素回归分析评估与淋巴结转移相关的因素。根据儿科ATA指南,将患者分为低、中、高风险组。在研究期间,共有86例患者(43%为男性;中位[IQR]年龄为12(10 - 14)岁)接受了手术。70例(82.4%)患者存在淋巴结转移,仅累及侧方(8%)和中央区(4.7%)以及两者均累及(88.6%)。65%的患者存在甲状腺外侵犯(ETE);35%为轻度;30%为广泛侵犯。单因素分析显示,男性患者、多灶性肿瘤、淋巴管侵犯和ETE中淋巴结转移更为常见。多因素分析显示,只有ETE可预测淋巴结疾病,比值比为8。与无ETE相比,轻度和广泛ETE均与淋巴结转移显著相关。低、中、高风险组的5年无病生存率分别为100%、95.7%和66%(<0.0001)。儿童DTC的淋巴结转移发生率异常高。ETE是淋巴结疾病的唯一最重要预测因素。ATA儿科风险分层有助于预测临床结果。